Faculty profile

Karine Tremblay

Back to faculty

ProfessorFMSS Département de pharmacologie-physiologieUniversité de Sherbrooke

Karine Tremblay

Professor

FMSS Département de pharmacologie-physiologie

Université de Sherbrooke

Sherbrooke, Quebec, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
12 publications in the last five years, latest in 2026.
Senior (last) author on 9 recent papers, a sign of leading a research group.
Principal investigator on 2 research grants (2 FRQS), most recently in 2020.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

1,209

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their Université de Sherbrooke profile.

Latest papers

Pharmacogenetic association study of cannabis use in chronic pain.
Journal of cannabis research · 2026 · senior author
Unbiased characterization of COVID-19 endotypes leads to prognostication of high-risk individuals using routine blood tests.
Communications medicine · 2026
Genetics and response to treatment with metformin for type 2 diabetes.
Pharmacogenomics · 2025 · senior author

All 24 publications

Latest funding

Plateforme intégrée d’innovations technologiques et d’application des connaissances en santé génétique (PI2TAC)
CFI · 2021 · Co-investigator
$320,100
Quelles sont les répercussions de la pandémie du COVID-19 sur la santé mentale des enfants de 5-12 ans, et quels sont les enjeux particuliers pour les enfants handicapés ou ayant une maladie chronique? Une scoping review des problématiques vécues et des pistes d'interventions prometteuses.
CIHR · 2020 · Co-investigator
$50,000
Établissement de jeunes chercheurs
FRQS · 2020 · Principal investigator
$60,000

All 5 grants and awards

24 publications.

Pharmacogenetic association study of cannabis use in chronic pain.

Beauchesne W, Turcotte J, Mercier P, Lavoie F, Tessier L, Gagnon AL, Allard C, Fortin E, Léonard G, Gendron L, Tremblay K

Journal of cannabis research2026Senior authorOpen Access

DOI: 10.1186/s42238-026-00408-w PMID: 41691361

Unbiased characterization of COVID-19 endotypes leads to prognostication of high-risk individuals using routine blood tests.

Ma W, Soulé A, Allard C, Durand M, Tremblay K, Rousseau S, Emad A

Communications medicine2026Open Access

DOI: 10.1038/s43856-026-01520-x PMID: 41832213

Genetics and response to treatment with metformin for type 2 diabetes.

Tessier L, St-Amour S, Simard D, Bouchard J, Perron P, Tremblay K

Pharmacogenomics20254 citationsSenior authorOpen Access

DOI: 10.1080/14622416.2025.2565992 PMID: 41031844

PCK1 and SLC22A2 gene variants associated with response to metformin treatment in type 2 diabetes.

St-Amour S, Tessier L, Harnois J, Allard C, Lavoie A, Caron P, Bouchard L, Perron P, Tremblay K

PloS one20253 citationsSenior authorOpen Access

DOI: 10.1371/journal.pone.0305511 PMID: 39928707

Evaluation of the implementation in primary care of genetic testing for the screening of MODY2 (iMOgene): protocol for an implementation pilot study.

Legeay S, Poitras ME, Tremblay-Vaillancourt V, Fournier A, Bouchard L, Leblanc J, Caron P, Savard C, Bettez N, Tremblay K

BMJ open2025Senior authorOpen Access

DOI: 10.1136/bmjopen-2024-089642 PMID: 39788778

Association of the TNFRSF1B-rs1061622 variant with nonresponse to infliximab in ulcerative colitis.

Tessier L, Gagnon AL, St-Amour S, Côté M, Allard C, Durand M, Bergeron D, Lavoie A, Michaud-Herbst A, Tremblay K

Scientific reports2025Senior author

DOI: 10.1038/s41598-025-02463-4 PMID: 40414945

Motivation to participate and attrition factors in a COVID-19 biobank: A qualitative study.

Jalbert L, Hautin AS, Baron M, Dubé È, Gagné M, Girard C, Larochelle C, LeBlanc A, Sasseville M, Décary S, Tremblay K

Journal of infection and public health20244 citationsSenior authorOpen Access

DOI: 10.1016/j.jiph.2024.01.004 PMID: 38262079

Long-Term Consequences of COVID-19 in Predominantly Immunonaive Patients: A Canadian Prospective Population-Based Study.

Benoit-Piau J, Tremblay K, Piché A, Dallaire F, Bélanger M, d'Entremont MA, Pasquier JC, Fortin M, Bourque C, Lapointe F, Betala-Belinga JF, Petit G, Jourdan G, Bahous R, Maya C, Benzina A, Faiyaz Hossain M, Peel MA, Houle O, Auger MS, Rioux A, Farand P

Journal of clinical medicine202312 citationsOpen Access

DOI: 10.3390/jcm12185939 PMID: 37762880

Moving towards the implementation of pharmacogenetic testing in Quebec.

Li LJ, Legeay S, Gagnon AL, Frigon MP, Tessier L, Tremblay K

Frontiers in genetics20235 citationsSenior authorOpen Access

DOI: 10.3389/fgene.2023.1295963 PMID: 38234998

Bacterial Biomarkers of the Oropharyngeal and Oral Cavity during SARS-CoV-2 Infection.

Bourumeau W, Tremblay K, Jourdan G, Girard C, Laprise C

Microorganisms20234 citationsOpen Access

DOI: 10.3390/microorganisms11112703 PMID: 38004715

Plateforme intégrée d’innovations technologiques et d’application des connaissances en santé génétique (PI2TAC)

Co-investigatorCFI2021John R. Evans Leaders Fund: John R. Evans Leaders Fund – Funding for research infrastructure

Principal investigators: Bouchard, Luigi

Keywords: Caractérisation phénotypique, Transfert/application connaissances, Développement tests génétiques/épigénétiques cliniques, Pharmacogénétique, Effet fondateur Études cohortes longitudinales, Biobanque

$320,100

Quelles sont les répercussions de la pandémie du COVID-19 sur la santé mentale des enfants de 5-12 ans, et quels sont les enjeux particuliers pour les enfants handicapés ou ayant une maladie chronique? Une scoping review des problématiques vécues et des pistes d'interventions prometteuses.

Co-investigatorCIHR2020Operating Grant: Knowledge Synthesis: COVID-19 in Mental Health & Substance Use

Principal investigators: Camden, Chantal; Malboeuf-Hurtubise, Catherine

Keywords: Collaboration École-Santé; Déterminants Socio-Culturels De La Santé; Enfants; Handicap; Maladies Chroniques; Santé Mentale

$50,000

Établissement de jeunes chercheurs

Principal investigatorFRQS2020Établissement de jeunes chercheurs

Principal investigators: Tremblay, Karine

Keywords: Non disponible

$60,000

Chercheurs-boursiers

Principal investigatorFRQS2020Chercheurs-boursiers

Principal investigators: Tremblay, Karine

Keywords: PHARMACOGENETIQUE/GENOMIQUE, MARQUEURS GENETIQUES, RECHERCHE CLINIQUE , REPONSE AUX MEDICAMENTS, TESTS PHARMACOGENETIQUES, RECHERCHE TRANSLATIONNELLE; Génétique humaine; Génétique de traits complexes; Génétique appliquée

$224,741

Déficience intellectuelle et maltraitance chez les enfants: Examen des facteurs et des conséquences associés et influence des services médicaux, sociaux et de réadaptation reçus

Co-investigatorCIHR2019Project Grant

Principal investigators: Paquette, Geneviève

Keywords: Adolescence; Analyse Comparatives; Analyses Associatives; Conséquences Sur La Santé Physique Et Mentale; Déficience Intellectuelle; Enfance; Facteurs De Risque; Maltraitance; Services De Santé; Services Sociaux

$550,800

From public funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998 with their latest competition results, the Canada Foundation for Innovation, Genome Canada, the Canadian Space Agency, Canada Research Chairs, the Fonds de recherche du Québec, Ontario research funding, Michael Smith Health Research BC, the Canadian Cancer Society, Heart & Stroke and Brain Canada.

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Karine Tremblay

Research

Latest papers

Latest funding

Pharmacogenetic association study of cannabis use in chronic pain.

Unbiased characterization of COVID-19 endotypes leads to prognostication of high-risk individuals using routine blood tests.

Genetics and response to treatment with metformin for type 2 diabetes.

PCK1 and SLC22A2 gene variants associated with response to metformin treatment in type 2 diabetes.

Evaluation of the implementation in primary care of genetic testing for the screening of MODY2 (iMOgene): protocol for an implementation pilot study.

Association of the TNFRSF1B-rs1061622 variant with nonresponse to infliximab in ulcerative colitis.

Motivation to participate and attrition factors in a COVID-19 biobank: A qualitative study.

Long-Term Consequences of COVID-19 in Predominantly Immunonaive Patients: A Canadian Prospective Population-Based Study.

Moving towards the implementation of pharmacogenetic testing in Quebec.

Bacterial Biomarkers of the Oropharyngeal and Oral Cavity during SARS-CoV-2 Infection.

Plateforme intégrée d’innovations technologiques et d’application des connaissances en santé génétique (PI2TAC)

Quelles sont les répercussions de la pandémie du COVID-19 sur la santé mentale des enfants de 5-12 ans, et quels sont les enjeux particuliers pour les enfants handicapés ou ayant une maladie chronique? Une scoping review des problématiques vécues et des pistes d'interventions prometteuses.

Établissement de jeunes chercheurs

Chercheurs-boursiers

Déficience intellectuelle et maltraitance chez les enfants: Examen des facteurs et des conséquences associés et influence des services médicaux, sociaux et de réadaptation reçus

Frequent collaborators

Sherif Elela

Sherif Abou Elela

Benoît Chabot

Catherine Allard

Jean-Philippe Brosseau

Luigi Bouchard

Simon Rousseau

Catherine Girard

Jean-Pierre Perreault

Marie-Eve Poitras

Samuel Legeay

Cynthia Gagnon

Catherine Larochelle

Raymund Wellinger

Catherine Laprise

Alain Piché

Amin Emad

Annie Leblanc

Ève Dubé

Mathieu Bélanger